| Literature DB >> 7881984 |
Abstract
Clinical and echocardiographic manifestations of cardiac disease are frequently present in patients starting end-stage renal disease therapy. Congestive heart failure, ischemic heart disease, systolic dysfunction, concentric left ventricular hypertrophy, and left ventricular dilatation are significant, adverse prognostic indicators, independent of age, diabetes mellitus, and smoking. Risk factors related to the uremic state, which are potentially reversible, include inadequate dialysis, anemia, hypoalbuminemia and hypocalcemia. Hypertension predisposes patients to congestive heart failure, following the development of which hypotension becomes an independent predictor of mortality.Entities:
Mesh:
Year: 1994 PMID: 7881984 DOI: 10.1097/00041552-199411000-00008
Source DB: PubMed Journal: Curr Opin Nephrol Hypertens ISSN: 1062-4821 Impact factor: 2.894